Profound Medical Inc is a Canadian medical technology company that develops and markets minimally invasive medical devices for the treatment of prostate cancer. The company's flagship product, TULSA-PRO, is a transurethral ultrasound ablation system that combines real-time MRI with transurethral ultrasound and closed-loop thermal feedback control to deliver precise ablation of the prostate while protecting surrounding tissue. The company is headquartered in Mississauga, Ontario, Canada and has operations in the United States and Europe.